Temasek ups India play with $151m Glenmark deal
This article was originally published in Scrip
Executive Summary
Singapore government investment arm Temasek is pumping in about INR9.45bn ($151.6m) for about 3.8% in Glenmark Pharmaceuticals – funds that the Indian firm expects to use to retire debt.